Skip to Content

POLITRATE DEPOT 3.75 MG POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION

Active substance(s): LEUPRORELIN ACETATE

View full screen / Print PDF » Download PDF ⇩
Transcript
Politrate Depot 3.75 mg
Module 1

Section 1.3

Page 1/11

Package leaflet: Information for the user

Politrate Depot 3.75 mg powder and solvent for prolonged-release suspension for
injection
leuprorelin acetate

Read all of this leaflet carefully before you start taking this medicine because it contains
important information for you.
-

Keep this leaflet. You may need to read it again.

-

If you have any further questions, ask your doctor or pharmacist.

-

This medicine has been prescribed for you only. Do not pass it on to others. It may harm
them, even if their signs of illness are the same as yours.

-

If you get any side effects talk to your doctor or pharmacist. This includes any possible
side effects not listed in this leaflet.

What is in this leaflet
1.

What Politrate Depot is and what it is used for

2.

What you need to know before you use Politrate Depot

3.

How to use Politrate Depot

4.

Possible side effects

5.

How to store Politrate Depot

6.

Contents of the pack and other information

1.

What Politrate Depot is and what it is used for

Politrate Depot is a vial containing a white powder, which is made into a suspension for
injection into a muscle. Politrate Depot contains the active ingredient leuprorelin (also called
leuprolide), which belongs to a group of medicines called luteinizing hormone releasing
hormone (LHRH) agonists (medicines that reduce testosterone – a sex hormone).

Your doctor has prescribed Politrate Depot for palliative treatment of advanced prostate
cancer.
Uk-pl-v22-renewal-clean

Politrate Depot 3.75 mg
Module 1

2.

Section 1.3

Page 2/11

What you need to know before you use Politrate Depot

Do not use Politrate Depot:
-

if you are allergic (hypersensitive) to LHRH, LHRH agonists or any of the other
ingredients of this medicine (listed in section 6). An allergic reaction may include rash,
itching, difficulty of breathing or swelling of the face, lips, throat or tongue.

-

if you have had an orchiectomy (removal of the testicles).

-

if you are female or a child.

-

Politrate Depot must not be used alone for the treatment of prostate cancer when the
spinal cord is compressed or the cancer has spread to the spine.

Warnings and precautions


Talk to your doctor or pharmacist before you are given Politrate Depot



Please tell your doctor if you have any of the following:
Any heart or blood vessel conditions, including heart rhythm problems (arrhythmia), or
are being treated with medicines for these conditions. The risk of heart rhythm problems
may be increased when using Politrate Depot.



Your condition may get worse at first during the first weeks of the treatment, but should
improve with continued treatment. Such signs and symptoms include: temporary increase
of testosterone (a male hormone), hot flushes, bone pain, nervous system disorders
(including depression) or urinary obstruction.



If you feel you have experienced an allergic reaction (shortness of breath, asthma, rhinitis,
swelling of the face, urticaria, skin eruption), stop using this medicine and inform your
doctor.



Tell your doctor if you might be at risk or if you have any of the following as you may
need more frequent check ups:


you suffer from any unexplained bruising or bleeding or if you feel generally
unwell. Although rare, these could be symptoms of changes in the number of
red or white cells



you have metabolic disease

Uk-pl-v22-renewal-clean

Politrate Depot 3.75 mg
Module 1



Section 1.3



you have heart problems, or a pounding heart beat



you have diabetes

Page 3/11

Your doctor should be aware of any previous personal clinical history of pituitary
adenoma (non-cancerous tumor of pituitary). Cases of pituitary apoplexy (partial tissue
loss of pituitary gland) have been described after initial administration of this type of drug
to patients with pituitary adenoma. Pituitary apoplexy may be manifested by sudden
headache, meningismus, visual disturbances or altered vision, even blindness, and
occasionally, decrease in the level of consciousness.



Your doctor should be aware if you suffer from a bleeding disorder, thrombocytopenia or
if you are on treatment with anticoagulants. Your liver function may need to be monitored
as changes to the liver and jaundice (yellow eyes and skin) have been reported with
leuprorelin treatment.



A fractured spine, paralysis, low blood pressure and high blood pressure have been
reported with leuprorelin treatment.



There have been reports of depression in patients taking Politrate Depot which may be
severe. If you are taking Politrate Depot and develop depressed mood, inform your doctor.



A decreased bone density (brittleness or thinning of the bones) has been reported with
leuproreline. Your doctor may consider adding an antiandrogen to the treatment with
Politrate Depot. Your doctor will be on the alert for inflamed veins (thrombophlebitis) and
other signs of clotting disorders and oedema (swelling of hands, feet or ankles). There is
an increased risk of these occurring in the case that an antiandrogen treatment is added to
Politrate Depot.



Tell your doctor, if you feel pressure on the spinal cord and/or experience urinary
disorders and/or haematuria (blood in the urine). In this case your doctor will be take if
necessary, additional precautions to avoid neurological complications (e.g. tingling in
hands and feet, paralysis) or obstruction of the urethra (the tube that connects the bladder
to the outside of the body). You will be closely supervised during the first weeks of
treatment.



Patients may experience metabolic changes (e.g. glucose intolerance or worsening of
existing diabetes), weight changes and cardiovascular disorders.

Uk-pl-v22-renewal-clean

Politrate Depot 3.75 mg
Module 1



Section 1.3

Page 4/11

Patients with metabolic or cardiovascular disease and especially patients with history of
congestive heart failure (condition in which the heart can no longer pump enough blood to
the rest of the body) should be monitored during treatment with leuprorelin.



You will need some blood tests during treatment, to check that Politrate Depot is being
efficacious.



You may experience a loss of interest in sexual intercourse, hot flushes and occasionally
there may be a reduction in size and function of the testes.



You may become fertile again when Politrate Depot treatment is stopped.



Politrate Depot may interfere with certain laboratory tests so make sure your doctor
knows you are using Politrate Depot



Politrate Depot contains an ingredient which may give a positive test result in doping
controls



Convulsions can occur in predisposed patients (those with a history of seizures, epilepsy,
cerebrovascular disorders, anomalies or central nervous system tumors), in patients
receiving drugs that can cause seizures and, to a lesser extent, in other patients who do not
have these characteristics.

Other medicines and Politrate Depot
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other
medicines. It may still be all right for you to be given Politrate Depot and your doctor will be
able to decide what is suitable for you.

Politrate Depot might interfere with some medicines used to treat heart rhythm problems
(e.g.quinidine, procainamide, amiodarone and sotalol) or might increase the risk of heart
rhythm problems when used with some other drugs(e.g. methadone (used for pain relief and
part of drug addiction detoxification), moxifloxacin (an antibiotic), antipsychotics used for
serious mental illnesses).

Pregnancy and breast-feeding
Politrate Depot is not indicated for use in women.
This medicine is contraindicated during pregnancy. Spontaneous abortions may occur if this
medicine is administered during pregnancy.
Uk-pl-v22-renewal-clean

Politrate Depot 3.75 mg
Module 1

Section 1.3

Page 5/11

Driving and using machines
Disturbance of vision and dizziness can occur during treatment. If affected you should not
drive or operate machinery.

Politrate Depot contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially
‘sodium- free’.

3.

How to use Politrate Depot

Dose
Politrate Depot must be given under the supervision of a doctor or a qualified health
practitioner.
Adults including the elderly:
The recommended dose of Politrate Depot is an injection once a month. The powder is made
up into a suspension and given as a single injection intramuscularly (into a muscle) once a
month (approximately every 28 to 33 days).
The injection site should be varied at regular intervals.
Politrate Depot must be administered via the intramuscular route only. Do not administer by
another route.

Use in children: Politrate Depot is not indicated for use in children..
The strength of your treatment is decided by your doctor.

If you use more Politrate Depot than you should
This is unlikely as your doctor or nurse will not know the correct dosage. However, if you
suspect you have received more than you should, let your doctor know about it immediately
so appropriate measures can be taken.

If you forget a dose of Politrate Depot
It is important not to miss a dose of Politrate Depot. As soon as you realise you have missed
an injection contact your doctor who will be able to give you your next injection.
Uk-pl-v22-renewal-clean

Politrate Depot 3.75 mg
Module 1

Section 1.3

Page 6/11

If you stop using Politrate Depot
Since the medical treatment involves administration of Politrate Depot for a long period,
when the treatment is interrupted you may experience a worsening of the symptoms related to
the disease. Therefore you must not interrupt the treatment prematurely without your doctor’s
permission.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4.

Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tell your doctor straight away if you get any sudden wheeziness, difficulty in breathing,
swelling of the eyelids, face or lips, rash or itching (especially affecting your whole
body).
The following side effects have been reported:

Very common (These may affect more than 1 in 10 people):
Hot flushes and injection site reactions.

Common (These may affect up to 1 in 10 people):
Night sweats, cold sweats, fatigue, headache, pyrexia (rise in body temperature), increased
appetite, erectile dysfunction, hyperhidrosis (increased sweating), asthenia (lack or loss of
strength), back pain and injection site reactions such as pain, irritation, discomfort, erythema
(redness of the skin), swelling (increment in size or inflation) bruising (contusion), mood
changes and depression in long term use of leuprorelin.

Uncommon (These may affect up to 1 in 100 people):
Breast swelling, breast tenderness, spinning sensation (vertigo), weakness, sleep disorders,
somnolence (sleepiness), insomnia ( not sleeping), low tummy pain, diarrhea, feeling sick
(nausea), vomiting, feeling hot and cold, feeling jittery, fever, yellow eyes and skin
(jaundice), changes in liver enzymes, anorexia (not eating), high cholesterol, joint pain,
Uk-pl-v22-renewal-clean

Politrate Depot 3.75 mg
Module 1

Section 1.3

Page 7/11

muscle spasms, pain in the hands and feet, decreased sex drive, mood alterations, urine
retention, frequent need to urinate, uncontrolled urine (incontinence), swelling around the
eyes, ejaculation failure, hyperlipidemia (high levels of blood lipids, pruritus (itching),
urticaria (nettle rash), mood changes depression in short term use of leuprorelin, and injection
site reactions such as: swelling, injury and hemorrhage.

Not known:
Cardiac disorders: Changes in ECG (QT prolongation).

Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side
effects not listed in this leaflet. You can also report side effects directly via the national
reporting system:
Yellow Card Scheme
Website: www.mhra.gov.uk/yellowcard
By reporting side effects you can help provide more information on the safety of this
medicine.

5.

How to store Politrate Depot

Your doctor or pharmacist will know how to store Politrate Depot.
Keep this medicine out of sight and reach of children.
Do not store above 25o C. Do not freeze.
Store in the original package, in order to protect from light
Do not use this medicine after the expiry date as indicated on the box, vial and pre-filled
syringe after "EXP". The syringe has the same expiry date to that of the vial. The expiry date
refers to the last day of that month.
Do not throw away any medicines via wastewater. Ask your pharmacist how to throw away
medicines you no longer use. These measures will help to protect the environment.
Uk-pl-v22-renewal-clean

Politrate Depot 3.75 mg
Module 1

6.

Section 1.3

Page 8/11

Contents of the pack and other information

What Politrate Depot contains
The active substance is leuprorelin acetate. Each vial contains 3.75 mg of leuprorelin acetate.
The other ingredients are: Polysorbate 80, Mannitol (E-421), Carmellose sodium (E-466),
Triethyl citrate and Poly(DL-lactide-co-glycolide) (PLGA).
The solvent contains (pre-filled syringe): mannitol, water for injection, sodium hydroxide (for
pH adjustment) and hydrochloric acid (for pH adjustment).
The concentration of the reconstituted product is 1.8 75 mg/ml.

What Politrate Depot looks like and contents of the pack
Each pack contains a vial with 3.75 mg of leuprorelin acetate, one prefilled syringe with 2 ml
of solvent, one adaptor system and one sterile 20 gauge needle.

Marketing Authorisation Holder and Manufacturer
GP-PHARM, S.A.
Pol ind Els Vinyets –els Fogars. Sector 2
Carretera comarcal 244, km22
08777 Sant Quintí de Mediona.
Spain

This medicinal product is authorised in the Member States of the EEA under the
following names:
Spain: Lutrate Depot 3.75 mg polvo y disolvente para suspensión de liberación prolongada
inyectable
Germany: Lutrate Depot 3.75 mg Pulver und Lösungsmittel zur Herstellung einer DepotInjektionssuspension
Portugal: Lutrate Depot 3.75 mg / 2 ml pó e veículo para suspensão injectável de libertação
prolongada
Greece: Lutrate Depot 3.75 mg Κόνις και διαλύτης για παρασκευή ενεσίμου εναιωρήματος
παρατεταμένης αποδέσμευσης
Uk-pl-v22-renewal-clean

Politrate Depot 3.75 mg
Module 1

Section 1.3

Page 9/11

Italy: Politrate
Sweden: Politrate 3.75 mg pulver och vätska till injektionväska, suspension
Hungary: Politrate Depot 3.75 mg
Denmark: Lutrate Depot
Finland: Lutrate 3.75 mg
Ireland: Leuprorelin 1-month Depot 3.75 mg powder and solvent for prolonged-release
suspension for injection
United Kingdom: Politrate Depot 3.75 mg powder and solvent for prolonged-release
suspension for injection
Belgium: Lutrate Depot 3.75 mg poeder en oplosmiddel voor suspensie voor injectie met
verlengde afgifte
The Netherlands: Leuproreline Lutrate Depot 3.75 mg poeder en oplosmiddel voor suspensie
voor injectie met verlengde afgifte
Norway: Lutrate Depot
Austria: Lutrate Depot 3.75 mg Pulver und Lösungsmittel zur Herstellung einer DepotInjektionssuspension
Estonia: Lutrate Depot 3.75 mg
Lithuania: Lutrate Depot 3.75 mg milteliai ir tirpiklis pailginto atpalaidavimo injekcinei
Latvia: Lutrate Depot 3.75 mg pulveris un šķīdinātājs ilgstošas darbības injekciju suspensijas
pagatavošanai
Czech Republic: Lutrate Depot 3.75 mg
Poland: Lutrate Depot
Slovak Republic: Lutrate Depot 3.75 mg
Romania: Lutrate Depot 3.75 mg pulbere şi solvent pentru suspensie injectabilă cu eliberare
prelungită
Bulgaria: Lutrate Depot

This leaflet was last revised in January 2016.

The following information is intended for healthcare professionals only:

How to prepare the injection?
Uk-pl-v22-renewal-clean

Politrate Depot 3.75 mg
Module 1

Section 1.3

Page 10/11

Follow these instructions carefully.
An aseptic technique should be observed during the reconstitution procedure.

Important:
Allow the product to reach room temperature before administration. Once mixed, the product
must be administered immediately.
This product is for single use only.
Verify the contents of the kit and make sure it includes everything that’s mentioned in the
leaflet.

The pack contains:
1 (one) vial of Politrate Depot 3.75 mg (leuprorelin acetate) powder for suspension for
injection
1 (one) pre-filled syringe containing the suspension solvent (mannitol 0.8% solution for
injection);
1 (one) device for reconstitution;
1 (one) single-use sterile needle.

Uk-pl-v22-renewal-clean

Politrate Depot 3.75 mg
Module 1

1

Section 1.3

Page 11/11

2

3

Attach the adaptor system (in
purple) to vial until a ‘clicking’
sound is heard

Affix the white finger-grip to the
diluents-containing syringe.
Remove the rubber cap from the
syringe and attach it to the
adaptor system

4

5

6

While keeping the syringe and
vial securely coupled in an
upright position, slowly push the
plunger in order to transfer all
the diluent into the vial

With the syringe still coupled to
the vial, shake the vial gently for
approximately one minute until
a
uniform
milky-white
suspension is obtained

Turn the system upside down,
and carefully pull out the
plunger
to
draw-up
the
resuspended drug from the vial
into the syringe

Remove blue cap from the vial

7

8

Detach the syringe and needle
from the adaptor system by
twisting the upper piece of the
adaptor counter-clockwise. The
drug is ready to be used.

Clean the injection area with an
alcohol swab and let the skin dry.
Inject
the
suspension
intramuscularly into the upper
outer quadrant of the gluteus

Uk-pl-v22-renewal-clean

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide